Literature DB >> 7389748

Effect of benzyl nicotinate on the percutaneous absorption of dexamethasone in the rat.

M A Kassem, K E Schulte.   

Abstract

The effect of benzyl nicotinate (15 mg) on the percutaneous absorption of dexamethasone 0,1 mg (62,5 uCi)/6 cm2, in an ethanol/octanol vehicle has been investigated in the rat. Both the urinary excretion and blood concentration data showed that benzyl nicotinate had a pronounced stimulating effect on the rate and extent of absorption. The relative bioavailability of dexamethasone was found to be 120% (urinary excretion data) or 146% (blood concentration data). Peak blood concentration increased greatly and was reached more quickly (1 1/2 hours instead of 2 1/2 hours).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389748     DOI: 10.1007/BF03189439

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Percutaneous absorption of hydrocortisone-4-C14 in two human subjects.

Authors:  F D MALKINSON; E H FERGUSON
Journal:  J Invest Dermatol       Date:  1955-11       Impact factor: 8.551

3.  Percutaneous absorption of dexamethasone estimated by a plasma radioimmunoassay.

Authors:  D Zirker; G G Krueger; A W Meikle
Journal:  J Invest Dermatol       Date:  1976-06       Impact factor: 8.551

4.  Percutaneous penetration of steroids in man.

Authors:  R J Feldmann; H I Maibach
Journal:  J Invest Dermatol       Date:  1969-01       Impact factor: 8.551

5.  Percutaneous absorption of steroids.

Authors:  R J Scheuplein; I H Blank; G J Brauner; D J MacFarlane
Journal:  J Invest Dermatol       Date:  1969-01       Impact factor: 8.551

  5 in total
  1 in total

1.  Degradation kinetics of benzyl nicotinate in aqueous solution.

Authors:  C J Mbah
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.